Description
Objectives
Upon completion of this workshop, the healthcare professional will be able to:
- Review a recent meta-analysis of 21 studies demonstrating that thyroxine does not improve symptoms or quality of life in patients with SCH.
- Recognize that there is no clear evidence that symptoms are related to serum TSH levels.
- Critique the reasons as to why experts make a strong recommendation against the use of thyroid hormones, even in symptomatic patients with significant elevation of TSH.
- Discuss their logic in recommendations against thyroid hormone use due to the “potential harm, lack of benefit, being burdensome of some patients because of long-term daily medication requirements, the cost of follow up visits and testing, all of which stress the patient without any benefits.”
- Evaluate an opinion by an esteemed psychiatrist that hypothyroid patients, or patients with hypothyroid symptoms, should not be evaluated or treated by endocrinologists.
Speakers
Neal Rouzier, MD
Faculty Chairman
Enrollment Options
Enroll today with a Premium Membership for $495/year, for access to THIS course and:
- All 1 Hour Accredited Courses
- All upcoming Accredited Monthly Webinars
- All upcoming Journal Clubs AND Journal Club Library
- EBSCOhost – research articles for the BHRT Workshop Series and to support your own evidence based studies!
